Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 5, 2014, Pages 556-565

  Chin, Calvin W L ^a,b   Semple, Scott ^a,c   Malley, Tamir ^a   White, Audrey C ^a   Mirsadraee, Saeed ^a,c   Weale, Peter J ^d   Prasad, Sanjay ^e   Newby, David E ^a,c   Dweck, Marc R ^a,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b DEPARTMENT OF CARDIOLOGY   (Singapore)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d Healthcare Sector   (United Kingdom)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

aortic stenosis; cardiac magnetic resonance imaging; Diffuse myocardial fibrosis; t1 mapping

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOBUTROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CONTRAST MEDIUM; ORGANOMETALLIC COMPOUND;

ADULT; AGE; AORTA STENOSIS; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC DYSFUNCTION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART RATE; HEART STROKE VOLUME; HEMATOCRIT; HUMAN; HYPERTENSION; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; REPRODUCIBILITY; SYSTOLIC BLOOD PRESSURE; T1 MAPPING; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; AGED; AORTA VALVE STENOSIS; CASE CONTROL STUDY; COMPARATIVE STUDY; DIAGNOSTIC USE; ECHOCARDIOGRAPHY; ECHOGRAPHY; FIBROSIS; HEART MUSCLE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES;

ADULT; AGED; AORTIC VALVE STENOSIS; CASE-CONTROL STUDIES; CONTRAST MEDIA; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS;

EID: 84898890012     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jet245     Document Type: Article

References (34)

1. Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 2011;58:1271-9.
2. Green JJ, Berger JS, Kramer CM, Salerno M. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. J Am Coll Cardiol Imag 2012;5:370-7.
3. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013;309:896-908.
4. Hein S, Arnon E, Kostin S, Schonburg M, Elsaser A, Polyakova V et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: Structural deterioration and compensatory mechanisms. Circulation 2003; 107:984-91.
5. Dez J, Querejeta R, Lo?pez B, Gonza?lez A, Larman M, Martinez Ubago JL. Losartandependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002;105:2512-7.
6. Lopez B, Gonzalez A, Diez J. Circulating biomarkers of collagen metabolism in cardiac diseases. Circulation 2010;121:1645-54.
7. KrayenbuehlHP, HessOM,MonradES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989;79:744-55.
8. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JAC. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011;57:891-903.
9. Messroghli DR,Walters K, Plein S, Sparrow P, Friedrich MG, Ridgway JP et al. Myocardial T1 mapping: Application to patients with acute and chronic myocardial infarction. Magn Reson Med 2007;58:34-40.
10. Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M et al. Human noncontrast T1 values and correlation with histology in diffuse fibrosis. Heart 2013; 99:932-37.
11. Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, FerreiraVMet al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. J Cardiovasc Magn Reson 2013;6:488-97.
12. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SNet al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52:1574-80.
13. SibleyCT, Noureldin RA, Gai N, Nacif MS, Liu S, Turkbey EB et al. T1 mapping in cardiomyopathy at cardiac MR: Comparison with endomyocardial biopsy. Radiology 2012;265:724-32.
14. Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: Normal distribution and elevation in acute and chronic infarction. Radiology 2001;218:703-10.
15. Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and subclinical myocardial pathology. Eur Heart J 2012;33:1268-78.
16. Kellman P, Wilson JR, Xue H, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 1: Evaluation of an automated method. J Cardiovasc Magn Reson 2012;14:63-74.
17. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans. Circulation 2010;122:138-44.
18. White SK, SadoDM, FontanaM, Banypersad SM,MaestriniV, FlettASet al.T1Mapping forMyocardial ExtracellularVolumeMeasurement byCMR: Bolus only versus primed infusion technique. J Am Coll Cardiol Imag 2013;6:955-62.
19. Flett AS, Sado DM, Quarta G, Mirabel M, Pellerin D, Herrey AS et al. Diffuse myocardial fibrosis in severe aortic stenosis: An equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovas Imaging 2012;33:819-26.
20. Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 2013;6:373-83.
21. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT et al. T1 mapping of the myocardium: Intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson 2012;14:26-35.
22. Kawel N, Nacif M, Zavodni A, Jones J. T1mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson 2012;14:27-37.
23. Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12:69-80.
24. Liu S, Han J, Nacif MS, Jones J, Kawel N, Kellman P et al. Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: Sample size considerations for clinical trials. J Cardiovasc Magn Reson 2012;14:90-8.
25. Oshinski JN, Delfino JG, Sharma P, Gharib AM, PettigrewRI. Cardiovascular magnetic resonance at 3.0T: Current state of the art. J Cardiovasc Magn Reson 2010;12: 55-68.
26. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22:1-23.
27. Xue HH, Shah SS, Greiser AA, Guetter CC, Littmann AA, Jolly M-PM et al. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med 2012;67:1644-55.
28. Huber A, Hayes C, Spannagl B, Rieber J, Klauss V, Schoenberg SO et al. Phasesensitive inversion recovery single-shot balanced steady-state free precession for detection of myocardial infarction during a single breathhold. Acad Radiol 2007;14: 1500-8.
29. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB,WuE, Bundy JM et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218:215-23.
30. Cerqueira MD,Weisman NJ, Dilsizian V, Jacobs AK, Kaul S, LaskeyWK et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
31. Portney LG, Watkins MP. Foundations of clinical research. New Jersey, United States: Pearson; 2009.
32. Gai N, Turkbey EB, Nazarian S, van der Geest RJ, Liu C-Y, Lima JACet al. T1 mapping of the gadolinium-enhanced myocardium: Adjustment for factors affecting interpatient comparison. Magn Reson Med 2010;65:1407-15.
33. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: A disease of the valve and the myocardium. J Am Coll Cardiol 2012;60:1854-63.
34. Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 2012;98:1436-41.